Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NitroMed (BiDil Drug Business)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a specialty pharmaceutical company. The company provides research and development efforts focuses on major diseases that are characterized by a deficiency in nitric oxide such as cardiovascular and inflammatory diseases.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 6000 Fairview Road
  • Suite 610
  • Charlotte, NC 28210
  • United States

NitroMed (BiDil Drug Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore NitroMed (BiDil Drug Business)‘s full profile, request access.

Request full access to PitchBook

NitroMed (BiDil Drug Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore NitroMed (BiDil Drug Business)‘s full profile, request access.

Request full access to PitchBook